Vapotherm, the medical equipment manufacturer in Exeter, last week received a delisting warning because from the New York Stock Exchange for not meeting capital and equity requirements, The notice ...

EXETER, N.H., Dec. 14, 2023 /PRNewswire/ -- Vapotherm, Inc. (NYSE: VAPO), ("Vapotherm" or the "Company") today announced it has received notice that the New York Stock Exchange ("NYSE") has determined ...

Vapotherm, Inc. (NYSE: VAPO) (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of its proprietary Vapotherm high velocity therapy ® ...

Exeter, New Hampshire-based medical technology company Vapotherm has secured up to US$52 million in debt financing through a combination of a term loan facility and a revolving credit facility. The ...

Vapotherm, Inc. (NYSE: VAPO) (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of its innovative, comfortable, non-invasive ...

The ventilator offers clinicians enhanced mobility and supports improved patient care. Credit: Olena Yakobchuk / Shutterstock.com. Vapotherm and Flight Medical have formed a partnership to introduce ...

Vapotherm, Inc. (NYSE: VAPO) is a publicly traded developer and manufacturer of advanced respiratory technology based in Exeter, New Hampshire, USA. The company develops innovative, comfortable, ...

EXETER, N.H.--(BUSINESS WIRE)--Vapotherm, Inc. (NYSE: VAPO) (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of its proprietary ...

Alger Mid Cap Focus Fund recently released its Q3 2020 Investor Letter, a copy of which you can download here. Class Z shares of the Alger Mid Cap Focus Fund outperformed the Russell Midcap Growth ...

For fiscal year 2021, the Company now expects revenue of at least $102 million, which reflects an increase of $17 million over the low end of our previously announced revenue guidance of $85 million ...